Antares Therapeutics
Recent Finacing
Series A
Recent Raise
$177M
Antares is a Scorpion Therapeutics spin-out developing small-molecule precision oncology drugs that leverage proprietary computational and experimental discovery to target previously inaccessible proteins, including transcription factors, with preclinical assets.
Highlights
Focus Areas
Biopharma
Biotechnology
Ediscovery
Health Care
Life Science
Manufacturing
Therapeutics
Recent Investors
Financials
$177M
Total Raised
1
Funding round
11
Investors